These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29536319)

  • 1. Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008-2011.
    Wilson LE; Pollack CE; Greiner MA; Dinan MA
    Breast Cancer Res Treat; 2018 Jul; 170(2):361-371. PubMed ID: 29536319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
    Dinan MA; Mi X; Reed SD; Hirsch BR; Lyman GH; Curtis LH
    JAMA Oncol; 2015 May; 1(2):158-66. PubMed ID: 26181015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
    Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
    JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy Costs and 21-Gene Recurrence Score Genomic Testing Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005 to 2011.
    Dinan MA; Wilson LE; Reed SD
    J Natl Compr Canc Netw; 2019 Mar; 17(3):245-254. PubMed ID: 30865923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgeon and medical oncologist peer network effects on the uptake of the 21-gene breast cancer recurrence score assay.
    Zipkin R; Schaefer A; Chamberlin M; Onega T; O'Malley AJ; Moen EL
    Cancer Med; 2021 Feb; 10(4):1253-1263. PubMed ID: 33455068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.
    Hershman DL; Buono D; McBride RB; Tsai WY; Joseph KA; Grann VR; Jacobson JS
    J Natl Cancer Inst; 2008 Feb; 100(3):199-206. PubMed ID: 18230795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women.
    Hershman DL; Buono D; McBride RB; Tsai WY; Neugut AI
    Cancer; 2009 Sep; 115(17):3848-57. PubMed ID: 19517470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer.
    Boero IJ; Gillespie EF; Hou J; Paravati AJ; Kim E; Einck JP; Yashar C; Mell LK; Murphy JD
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):571-580. PubMed ID: 28126306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of 21-Gene Assay (OncotypeDX) Testing and Receipt of Chemotherapy in the Medicare Breast Cancer Patient Population Following Initial Adoption.
    Dinan MA; Wilson LE; Reed SD; Griggs JJ; Norton EC
    Clin Breast Cancer; 2020 Dec; 20(6):487-494.e1. PubMed ID: 32653473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologists' influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?
    Katz SJ; Hawley ST; Bondarenko I; Jagsi R; Ward KC; Hofer TP; Kurian AW
    Breast Cancer Res Treat; 2017 Oct; 165(3):751-756. PubMed ID: 28689364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.
    Kurian AW; Bondarenko I; Jagsi R; Friese CR; McLeod MC; Hawley ST; Hamilton AS; Ward KC; Hofer TP; Katz SJ
    J Natl Cancer Inst; 2018 May; 110(5):493-500. PubMed ID: 29237009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance testing among survivors of early-stage breast cancer.
    Keating NL; Landrum MB; Guadagnoli E; Winer EP; Ayanian JZ
    J Clin Oncol; 2007 Mar; 25(9):1074-81. PubMed ID: 17369571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?
    Jasem J; Fisher CM; Amini A; Shagisultanova E; Rabinovitch R; Borges VF; Elias A; Kabos P
    J Natl Compr Canc Netw; 2017 Apr; 15(4):494-503. PubMed ID: 28404760
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
    Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
    Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total Mastectomy or Breast Conservation Therapy? How Radiation Oncologist Accessibility Determines Treatment Choice and Quality: A SEER Data-base Analysis.
    Churilla TM; Donnelly PE; Leatherman ER; Adonizio CS; Peters CA
    Breast J; 2015; 21(5):473-80. PubMed ID: 26133235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second Opinions From Medical Oncologists for Early-Stage Breast Cancer: Prevalence, Correlates, and Consequences.
    Kurian AW; Friese CR; Bondarenko I; Jagsi R; Li Y; Hamilton AS; Ward KC; Katz SJ
    JAMA Oncol; 2017 Mar; 3(3):391-397. PubMed ID: 28033448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Physician Peer Influence With Subsequent Physician Adoption and Use of Bevacizumab.
    Keating NL; O'Malley AJ; Onnela JP; Gray SW; Landon BE
    JAMA Netw Open; 2020 Jan; 3(1):e1918586. PubMed ID: 31899533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated with Multidisciplinary Consultations in Patients with Early Stage Breast Cancer.
    Quyyumi FF; Wright JD; Accordino MK; Buono D; Law CW; Hillyer GC; Neugut AI; Hershman DL
    Cancer Invest; 2019; 37(6):233-241. PubMed ID: 31296072
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of a Novel Network-Based Linchpin Score to Characterize Accessibility to the Oncology Physician Workforce in the United States.
    Moen EL; Brooks GA; O'Malley AJ; Schaefer A; Carlos HA; Onega T
    JAMA Netw Open; 2022 Dec; 5(12):e2245995. PubMed ID: 36525275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologist and organizational factors associated with variation in breast cancer multigene testing.
    Lieu TA; Ray GT; Prausnitz SR; Habel LA; Alexeeff S; Li Y; Ramsey SD; Phelps CE; Chawla N; C O'Neill S; Mandelblatt JS
    Breast Cancer Res Treat; 2017 May; 163(1):167-176. PubMed ID: 28224383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.